NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy

Author： Civallero Monica   Cosenza Maria   Marcheselli Luigi   Pozzi Samantha   Sacchi Stefano  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.11, 2012-11, pp. : 1597-1606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Studies of NVP-BEZ235 in Melanoma

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 165-174

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets in mantle cell lymphoma

By Martin Peter   Leonard John P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 929-940

Informa Healthcare

Access to resources Recommend Favorite

Current Management of Mantle Cell Lymphoma

By Weigert Oliver   Unterhalt Michael   Hiddemann Wolfgang   Dreyling Martin  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1689-1702

Adis International

Access to resources Recommend Favorite

Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 110-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine alone or in combination with cisplatin cost effective in NSCLC

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite